ArticleInorganic chemistry2026
Metal-dependent Structure, Solution Properties, and Redox-Mediated Anticancer Activity of Rhodium(III) and Iridium(III) Half-Sandwich Phenanthroline-Sulfonamide Complexes.
Article in Inorganic chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
A phenanthroline-bearing sulfonamide ligand (L) and its half-sandwich rhodium(III) and iridium(III) complexes, [(η5-Cp*)RhCl(L)]PF6 (1) and [(η5-Cp*)IrCl(L)]PF6 (2), were synthesized to determine how metal coordination and metal identity influence structure, solution properties, and anticancer responses. Single-crystal X-ray diffraction established closely related piano-stool geometries with bidentate N,N-coordination of L, while spectroscopic analyses confirmed the complexes in solution. All compounds were spectroscopically stable for 72 h under the tested conditions. Coordination shifted the lipophilicity of L (log P = 0.78) to hydrophilic values for 1 and 2 (-0.65 and -0.91, respectively). The complexes weakly inhibited carbonic anhydrase II and displayed low-affinity binding to human serum albumin; the CT-DNA UV-vis experiment was inconclusive because of substantial spectral overlap and was not used to assign a DNA-binding mode. L showed submicromolar-to-low-micromolar cytotoxicity across four cancer cell lines and pronounced time-dependent mitochondrial depolarization in NALM-6 cells. Complex 2 retained micromolar potency but showed weak overall cancer/nonmalignant discrimination, whereas 1 showed a marked preference for NALM-6 cells (IC50 = 4.41 μM; HEK-293 IC50 > 100 μM). In NALM-6 cells, 1 produced a pronounced ROS increase at 6 h that preceded prominent γH2AX signaling, caspase-3/7 activation, and apoptosis at 24-48 h, while mitochondrial depolarization remained comparatively limited. This temporal ordering is consistent with a redox-associated cellular response but does not by itself establish ROS causality or exclude mitochondrial involvement. These matched analogs demonstrate that Rh(III) versus Ir(III) coordination can reprogram physicochemical and cellular response profiles within the same ligand scaffold and identify 1 as a candidate for further mechanism-guided optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.